FOR IMMEDIATE RELEASE
Contact:
David W. Moskowitz MD
CEO, GenoMed
Tel. 314.983.9933
dwmoskowitz@genomed.com
Skype ID: dwmoskowitz
Elizabeth Gannon
President, National Health Services
Tel. 941-391-5991
elizabeth.gannon@n-h-s.com
Skype ID: gannon.elizabeth
ST. LOUIS—March 24, 2009—GenoMed® (OTC Pink Sheets GMED.PK) announced today that it is partnering with National Health Services (NHS) to offer GenoMed’s Next Generation Disease Management services to NHS clients and their patient populations.
David Moskowitz MD, GenoMed’s CEO, said, “NHS heard about us because of the Free Medical Advice™ program we recently announced.”
Elizabeth Gannon, President of National Health Services, agreed, “We want to make prevention easy and accessible for the patient. GenoMed’s recent plan to offer free medical consultations over Skype® seems like a great new way to deliver telemedicine.”
Continued Ms. Gannon, “NHS wants to expose our patient populations to the very dynamic, useful and affordable ways to treat diabetes, high blood pressure and emphysema that GenoMed has pioneered.”
National Health Services is launching an updated version of the 2002 e-Health & Wellness portal and web site, MyHealthyLifestyle.com originally created in 2002, followed by the campaign “MyHealthyLifestyle® USA” to coincide with National Workplace Wellness Week, beginning in April.
Ms. Gannon ended by saying, “The all new My Healthy Lifestyle® web site portal will afford free access to all and was created for all to take advantage of basic wellness services and education so greatly needed in our everyday life and to supply direct to consumer access to group purchasing. Beyond wellness services, National Health Services also provides resources and affordable health services nationwide for those in need of ongoing and extended care, the under-insured and the un-insured.”
About National Health Services
Founded in 1994, National Health Services is the result of an evolution of expertise and product development. A provider of cost containment strategies and wellness solutions across the healthcare sector, NHS is a technology driven Healthcare Solutions Company that specializes in turnkey end-to-end health solutions and delivery platforms for employers, consumers, brokers/agents, physicians and health plans. systems integration, technology solutions and web-enablement for the Health and Wellness space.
About GenoMed
GenoMed has already published superior clinical outcomes for diabetes, high blood pressure, and emphysema. For these diseases, GenoMed can recommend its Clinical Outcomes Improvement Program, or COIP®, which costs $75/month, confident that it can provide better patient outcomes than anybody else in the world. For many additional diseases, GenoMed can offer a free clinical trial. Please contact Dr. Moskowitz (see contact info above).
Safe Harbor Statement
This press release contains forward looking statements, including those statements pertaining to GenoMed, Inc.’s (the Company’s) finances and treatments. The words or phrases “ought to,” “should,” “could,” “may,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those projected in the forward looking statements as a result of a number of risks and uncertainties, including but not limited to our research and development being subject to scientific, economic, regulatory, governmental, and technological factors, and the possibility of our not being able to field all the calls and emails we receive. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we specifically disclaim any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.